Celebrating 150 Years
“When it is complete, the office renovation will reflect our focus on innovation, local investment and our continued contributions to cultivate solutions to the world’s most pressing agricultural issues,” said Blome.
RESEARCH TRIANGLE PARK, N.C. (PRWEB) October 17, 2013
Committed to long-term investment in North Carolina’s Research Triangle Park (RTP) community, Bayer CropScience today announced the beginning of renovations to its North American headquarters. The $33 million project, scheduled for completion in 2015, will allow the company to accommodate substantial growth and bring more of its employees together over the next decade. Completed facilities will eventually house more than 700 employees working to cultivate the latest developments in sustainable agricultural solutions.
“Bayer CropScience is dedicated to being a pivotal organization in the socio-economic life of RTP,” said Jim Blome, president and CEO of Bayer CropScience LP. “Revitalizing our current office space to accommodate growth marks a significant investment for Bayer CropScience in the area. By using our facilities to attract and retain the region’s top talent, we are ensuring that Bayer CropScience will continue to contribute to RTP’s viability and reputation as a top location for business and scientific development.”
The company’s office renovation is the latest in a series of recent investments in the RTP area. Noting the area’s potential for promoting bioscience growth and innovation through community and economic investment, Bayer CropScience moved the company’s global Seeds headquarters from France to RTP in 2012. Other initiatives at the North American headquarters include opening a $20 million, 60,000-square-foot greenhouse; a $2.1 million, 6,000-square-foot state-of-the-art North American Bee Care Center; and a $16.1 million, 40,000-square-foot Development North America research facility. The greenhouse, which is being used for soy, corn and other broadacre crop research, serves as one of the country’s premier locations for bioscience research and development. It boasts numerous environmentally-friendly features, including a 70,000 gallon underground water storage tank that will harvest rainwater for plant irrigation and is expected to reduce consumption of potable water at the facility by approximately 700,000 gallons annually.
The company also recently invested $6.2 million in the purchase of 70 acres of land north of its current property at the intersection of T.W. Alexander Drive and North Carolina Highway 147 from the Research Triangle Foundation to allow for future facility expansion.
The renovated modern facility will enhance collaboration among employees by offering various work environments for individual work and meetings. The building will be designed to Leadership in Energy and Environmental Design (LEED) certification standards, including LED lighting and highly efficient mechanical systems. In addition, the renovated building offers increased natural light, a wellness center with a medical office, an employee store, and a dedicated conference center. Natural materials and modern design elements will be used throughout the building, reflecting the relationship between agriculture and the high-tech work Bayer employees do each day to feed a growing population.
“When it is complete, the office renovation will reflect our focus on innovation, local investment and our continued contributions to cultivate solutions to the world’s most pressing agricultural issues,” said Blome. “We are excited to begin the process, which started earlier this month, and we look forward to showcasing a new look in the coming years.”
For more information on Bayer CropScience, visit http://www.bayercropscience.us, connect on the Bayer CropScience social media hub, http://connect.bayercropscience.us, or follow us on Twitter @Bayer4CropsUS.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company is celebrating 150 years of Bayer – consistent with its mission of “Bayer: Science For A Better Life.” Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at: press.bayercropscience.com.
Contact:
Media can utilize the hotline at 1-866-99-BAYER, or contact
Becca Hogan
External Communications Manager
Bayer CropScience
Tel: (919) 549-2998
Email: becca.hogan(at)bayer(dot)com
Twitter: @bayer4cropus
#bayer150
Jennifer Fair
MMI Public Relations
Tel: (919) 233-6600
Email: jennifer(at)mmipublicrelations(dot)com
(USA-BCS-2013-0293)
©2012 Bayer CropScience LP, 2 T.W. Alexander Drive, Research Triangle Park, NC 27709. Always read and follow label instructions. Bayer (reg’d), the Bayer Cross (reg’d) are trademarks of Bayer. For additional product information call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our Web site at BayerCropScience.us.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.